Your account is not claimed yet. You can sign up with ORCID to claim your account.

Fredrik Erlandsson

Years Active: 2018-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Susanne Johansson, David Han, Thomas Hunt, Karin Björck, Delia Florica, Michael Gillen, Jesse Hall, Fredrik Erlandsson
Pharmacokinetics, pharmacodynamics, and safety of verinurad with and without allopurinol in healthy Asian, Chinese, and non-Asian participants. Pharmacology research & perspectives 10 (3) (2022)
Matthieu Legrand, Sean M Bagshaw, Jay L Koyner, Ivonne H Schulman, Michael R Mathis, Juliane Bernholz, Steven G Coca, Martin Gallagher, Stephane Gaudry, Kathleen D Liu, Ravindra L Mehta, Romain Pirracchio, Abigail Ryan, Dominik Steubl, Norman Stockbridge, Fredrik Erlandsson, Alparslan Turan, Francis P Wilson, Alexander Zarbock, Michael P Bokoch, Jonathan D Casey, Patrick Rossignol, Michael O Harhay
Optimizing the Design and Analysis of Future AKI Trials. Journal of the American Society of Nephrology : JASN 33 (8) (2022)
Fredrik Erlandsson, Muna Albayaty, Ligia Chialda, Hans Ericsson, Carl Amilon, Karin Nelander, Rasmus Jansson-Löfmark, Linda Wernevik, Magnus Kjaer, Krister Bamberg, Judith Hartleib-Geschwindner
Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator. British journal of clinical pharmacology 84 (7) (2018)

Fredrik Erlandsson.css-eqlu8i{font-size:small;padding-left:4px;}